• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Dime Bancorp

Dime Bancorp

  1. Regeneron Announces EYLEA® (aflibercept) Injection Approved for the Treatment of Diabetic Macular Edema (DME ) in Japan

    Regeneron Announces EYLEA® (aflibercept) Injection Approved for the Treatment of Diabetic Macular Edema ( DME ) in Japan

  2. pSivida Reports ILUVIEN® Granted Marketing Authorization in Belgium

    pSivida Reports ILUVIEN® Granted Marketing Authorization in Belgium

  3. Regeneron Reports Third Quarter 2014 Financial and Operating Results

    Regeneron Reports Third Quarter 2014 Financial and Operating Results

  4. Research and Markets: Methanol - 2014 Global Strategic Business Report

    Research and Markets: Methanol - 2014 Global Strategic Business Report

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.